Recro, Teva Extend License and Supply Agreement
Recro Gainesville, the contract development and manufacturing organization (CDMO) division of Recro Pharma, has amended its existing license and supply agreement with ...
April 18, 2019
by contractpharma
Numab & Intarcia Enter License Agreement
Intarcia Therapeutics Inc. has executed its option to in-license ND016, being developed for the treatment of autoimmune disorders
March 7, 2019
by contractpharma
WuXi STA, Ark Biosciences Sign CMC Devt. & Mfg. Deal
The CDMO will provide Ark with integrated services for in process R&D and manufacturing
March 7, 2019
by contractpharma
Amgen, Molecular Partners Enter Immunotherapy Alliance
Amgen and Molecular Partners AG, a biotech company developing DARPin therapeutics, have entered a collaboration and license agreement for the clinical development and commercialization of MP0310...
December 21, 2018
by contractpharma
Chi-Med and Lilly Amend 2013 Agreement
Hutchison China MediTech has announced a change (“2018 Amendment”) to the 2013 License and Collaboration Agreement on fruquintinib with Lilly Shanghai, an affiliate of Eli Lilly and Company.
December 21, 2018
by contractpharma
Orchard & SIRION Enter License Agreement
Orchard Therapeutics and SIRION Biotech GmbHhave entered into a license agreement, through which Orchard has licensed SIRION’s LentiBOOST™ technology to enhance manufacturing efficiency for certain of Orchard’s ex vivo
December 17, 2018
by contractpharma
Entera & Amgen Sign Research Agreement
Entera Bio has entered into a research collaboration and license agreement with Amgen in inflammatory disease and other serious illnesses.
December 12, 2018
by contractpharma
TRACON & I-Mab Partner for Immuno-Oncology
TRACON Pharmaceuticals and I-Mab Biopharmajointly announced the establishment of a series of strategic collaborative partnerships for developing multiple immuno-oncology programs, including I-Mab’s proprietary CD73 antibody TJD5
November 30, 2018
by contractpharma
Immunocore, Genentech Expand Anti-Cancer Alliance
Immunocore Ltd., a T Cell Receptor (TCR) biotechnology company, has entered into a new partnership with Genentech, a member of the Roche Group, to expand an existing discovery
November 28, 2018
by contractpharma
CBT, Bossan Enter Clinical Collaboration
CBT Pharmaceuticals (CBT) and Zhejiang Bossan Pharmaceutical Co., Ltd (Bossan) have entered into a clinical collaboration and license agreement to develop their respective assets in combination with each other.
November 27, 2018
by contractpharma
Celltrion signs agreement for atherosclerosis drugs development
Celltrion will have a preferential right to license-in the new drug candidates
October 15, 2018
by biospectrumasia
Novartis Enters into License Agreement with Galapagos, MorphoSys
Novartis has entered into an exclusive license agreement with biotech companies Galapagos NV, Mechelen and MorphoSys regarding their compound MOR106.
July 24, 2018
by americanpharmaceuticalreview